Pfizer Vaccines: A Budding Portfolio Of Long-Term Opportunities

Pfizer sees long-term growth potential in vaccines, fueled by new products targeted to patients across their life, from unborn children to seniors, including a portfolio of vaccines targeted to pregnant women and therapeutic cancer vaccines.

For many years Pfizer Vaccines has been a one-trick pony, but now Pfizer Inc. is looking to grow its vaccines business beyond Prevnar and is ready to invest in new, untapped opportunities.

More from Clinical Trials

More from R&D